Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19

Mostrar otras versiones (1)

The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated disease COVID-19, requires therapeutic interventions that can be rapidly identified and translated to clinical care. Traditional drug discovery methods have a >90% failure rate and can take 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabelli, Carmen, Wotring, Jesse W., Zhang, Charles J., McCarty, Sean M., Fursmidt, Reid, Pretto, Carla D., Qiao, Yuanyuan, Zhang, Yuping, Frum, Tristan, Kadambi, Namrata S., Amin, Anya T., O’Meara, Teresa R., Spence, Jason R., Huang, Jessie, Alysandratos, Konstantinos D., Kotton, Darrell N., Handelman, Samuel K., Wobus, Christiane E., Weatherwax, Kevin J., Mashour, George A., O’Meara, Matthew J., Chinnaiyan, Arul M., Sexton, Jonathan Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433531/
https://www.ncbi.nlm.nih.gov/pubmed/34413211
http://dx.doi.org/10.1073/pnas.2105815118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433531/
https://www.ncbi.nlm.nih.gov/pubmed/34413211
http://dx.doi.org/10.1073/pnas.2105815118

Ejemplares similares